Navigation Links
Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales Conference
Date:7/13/2009

>), Access Pharmaceuticals (OTC Bulletin Board: ACCP), Echo Therapeutics (OTC Bulletin Board: ECTE), Raptor Pharmaceuticals (OTC Bulletin Board: RPTP), Neoprobe Corp. (OTC Bulletin Board: NEOP) and Oxygen Biotherapeutics (OTC Bulletin Board: OXBO).

Jesup's annual conference provides its clients a distinctive forum in which to visit with and hear presentations from unique growth companies in the life sciences, healthcare, aerospace and transportation industries. The conference commences with Life Science industry and investor panels on Wednesday July 29th with Company presentations on Thursday July 30th, followed by Investment Products presentations on August 1st and 2nd. Last year's conference brought together hundreds of institutional and retail investors in an intimate format.

For more information or registration to present or attend, contact your Jesup salesperson, Donald A. Wojnowski at dwojnowski@jesuplamont.com or Tammy Kraus at tkraus@jesuplamont.com. You can also register online at www.jesuplamontconferences.com.

About Jesup & Lamont, Inc.

Established in 1877, Jesup & Lamont, Inc. has an extensive history on Wall Street, with its origins encompassing such successes as providing brokerage services to Standard Oil and raising capital for the construction of Rockefeller Center. Jesup & Lamont, through its two wholly owned brokerage subsidiaries, offers full service broker-dealer and registered investment advisory services through its approximately 150 retail brokers in over 20 locations including offices in New York,
'/>"/>

SOURCE Jesup & Lamont, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pharsight to Present at Jesup and Lamont 2008 Emerging Growth Stock Conference
2. Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System
3. MacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile Virus
4. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2009 Financial Results
5. Mirixa Corporation Announces Key New Hires
6. Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia
7. Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment for Obesity
8. Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Charter Amendments
9. DOR BioPharma Announces Issuance of European Patent for its LPM(TM) Oral Drug Delivery Technology
10. Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders
11. Enerkem Announces World-Class Advanced Energy Research Center in Edmonton, Alberta, Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Muncie, IN (PRWEB) August 22, 2014 ... aviation community and its members in Alaska that Alaska ... House Concurrent Resolution 15, further defining public use of ... Aircraft Systems Task Force. House Bill 255states that it ... relating to images captured by an unmanned aircraft system.” ...
(Date:8/22/2014)... August 22, 2014 “Our nation's ... is a national disgrace. Furthermore, every governmental and ... the current, deplorable state of unorganized dysfunction shares ... mistakes," to merely serve as a device to ... of colossal failure(s) that have accumulated through the ...
(Date:8/21/2014)... Finnish-Swedish research group at the Institute for Molecular ... institutet, Stockholm, has developed a novel "man and ... This innovative diagnostic aid was described in ... The method is based on computer vision algorithms ... combined with visualization of only the diagnostically most ...
(Date:8/21/2014)... August 21, 2014 ... has announced the addition of the  "Global ... their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... therapy, is a means of replacing hormones ... the body. This type of therapy is ...
Breaking Biology Technology:State of Alaska Signs Unmanned Aircraft Systems Bill 25 Great Mistakes in Healthcare and How to Fix Them by Dr. Ira Williams 2A novel 'man and machine' decision support system makes malaria diagnostics more effective 2Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk 2
... , COLLEGEVILLE, Pa., Aug. 11 Wyeth ... it received notice that the action date for the U.S. Food ... License Application (BLA) for Prevnar 13(TM), (Pneumococcal 13-valent ... 2009, to December 30, 2009. In response to an FDA ...
... , , PORTLAND, Ore., Aug. ... announce patent award approval on August 11 to Dimera Incorporated for ... known as Peripheral Vascular Disease (PVD). , , ... (Number 7572780 ) covers the period August 11, 2009 through ...
... ... sugar feedstocks, , ... (Vocus) August 11, 2009 -- BP and Martek Biosciences Corporation (Nasdaq: MATK), today announced ... microbial oils for biofuels applications. The partnership combines a broad technology platform and operational ...
Cached Biology Technology:Wyeth Provides Regulatory Update on Prevnar 13* in the United States 2Wyeth Provides Regulatory Update on Prevnar 13* in the United States 3Wyeth Provides Regulatory Update on Prevnar 13* in the United States 4Wyeth Provides Regulatory Update on Prevnar 13* in the United States 5Wyeth Provides Regulatory Update on Prevnar 13* in the United States 6Peripheral Artery Disease (PAD) Patent Granted to Dimera 2BP and Martek Biosciences Enter Joint Development Agreement to Deliver Advanced Biodiesels 2BP and Martek Biosciences Enter Joint Development Agreement to Deliver Advanced Biodiesels 3BP and Martek Biosciences Enter Joint Development Agreement to Deliver Advanced Biodiesels 4
(Date:8/22/2014)... RIVERSIDE, Calif. Thomson Reuters , a leading ... five researchers at the University of California, Riverside in ... brightest minds of our times." , To generate the ... (2002-2012) to identify researchers whose published work has had ... included among some 3,200 individuals who published the greatest ...
(Date:8/22/2014)... remember the after-effects, including pain, swelling or redness. These ... the injury. When tissue in the body is damaged, ... An inflammatory response acts as a protective mechanism to ... after injuries such as wounds and burns. However, the ... which foreign material is introduced, for example when synthetics ...
(Date:8/22/2014)... reductase (DHCR24) is a multifunctional enzyme ... and has neuroprotective and cholesterol-synthesizing activities. ... caused by amyloid β deposition. Dr. ... University in China constructed two recombinant ... DHCR24 expression specifically in neuronal cells. ...
Breaking Biology News(10 mins):5 UC Riverside scientists among world's most influential scientific minds 2Tissue regeneration using anti-inflammatory nanomolecules 2
... supermarket headlines tell us so., Inquiring Texas research minds ... tiny, sometimes obscure pest that can damage plants during ... cotton for about four weeks," said Dr. Megha Parajulee, ... feed on new plant growth, primarily the first small ...
... ago, "ultraconserved elements" were discovered in the genomes of mice, ... in length or longer -- some are over 700 base ... three species. They have been perfectly conserved since the last ... 85 million years ago. These and other highly ...
... cells could take a mix of enzyme ingredients, blend ... elaborate chemical structure such as penicillin. Researchers at UC ... of Pharmacy and Pharmaceutical Sciences and the University of ... to mimic this process outside of a cell. ...
Cached Biology News:Inquiring minds want to know about cotton fleahoppers 2Inquiring minds want to know about cotton fleahoppers 3Ultraconserved elements in the genome: Are they indispensable? 2Ultraconserved elements in the genome: Are they indispensable? 3Ultraconserved elements in the genome: Are they indispensable? 4Researchers develop simple method to create natural drug products 2
... continuous vertical flow of 99.99% particle-free air ... standards , Stainless steel enclosure ... , Large, ergonomically sloped polycarbonate viewing ... filling machines or other large process equipment ...
... biocompatibility testing at various temperatures, this ... through a clean heating unit to ... to 140F. Transparent panels allow full ... easy access to the work area. ...
Ideal for chemical processing that requires downward flow of exhaust fumes. Powderful 1200 CFM blower draws fumes into sub-surface bonded charcoal filter for safe removal of organic vapors (final HEP...
... The Label IT siRNA Tracker Intracellular Localization ... directly label and deliver siRNA, of your ... for in vitro tracking experiments. Subcellular localization ... can be monitored following introduction of the ...
Biology Products: